Researchers studied QBP1, a peptide that blocks the self-assembly of CPEB3, a protein involved in forming long-term memories. In laboratory tests, the active part of QBP1 inhibited the amyloid form of human CPEB3 without affecting another process called phase separation.

The team then created mice that continuously produced QBP1. These mice had weaker consolidation of simple and aversive memories after 24 hours, while their short-term memory was unchanged. In a PTSD-like experiment, they showed more extinction of the traumatic memory and less anhedonia than control mice. The findings support further testing of CPEB3 blocking in pharmacological or post-developmental models.